Myriad Genetics Announces Second Quarter Fiscal 2009 Financial Results Conference Call

Myriad Genetics, Inc. (NASDAQ: MYGN) has arranged a conference call with the management team to provide a company update. Peter D. Meldrum, President and Chief Executive Officer, will host the call along with Jim Evans, Chief Financial Officer, Gregory C. Critchfield, M.D., President of Myriad Genetic Laboratories, Inc., and Adrian N. Hobden, Ph.D., President of Myriad Pharmaceuticals, Inc.

Date: February 3, 2009
Time: 10:00 a.m. Eastern Time, Please dial in between 9:45 and 10:00 a.m.
Call-in Number: (800) 736-4610 or (212) 231-2902
Reservation Number: 21411489

A live audio webcast will be made available at www.myriad.com.

A press release will be issued at 6:30 a.m. Eastern Time on February 3, 2009.

Replay of the call will be available beginning two hours after the end of the call until 7 days following the call and may be heard by dialing (80... or (40..., and entering the reservation number listed above.

Source